Cargando…
Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors()
Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) are overexpressed in the majority of renal cell carcinomas. This characteristic has supported the rationale of targeting VEGF-driven tumour vascularization, especially in clear cell RCC. VEGF-inhibiting strategies include the use of...
Autores principales: | León-Mateos, L., Mosquera, J., Antón Aparicio, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588456/ https://www.ncbi.nlm.nih.gov/pubmed/26386874 http://dx.doi.org/10.1016/j.redox.2015.09.007 |
Ejemplares similares
-
Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension
por: Kruzliak, Peter, et al.
Publicado: (2012) -
Nitric Oxide as a Central Molecule in Hypertension: Focus on the Vasorelaxant Activity of New Nitric Oxide Donors
por: da Silva, Gabriela Maria, et al.
Publicado: (2021) -
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001()
por: Scicinski, Jan, et al.
Publicado: (2015) -
A Comparative Study of Inhaled Nitric Oxide and an Intravenously Administered Nitric Oxide Donor in Acute Pulmonary Hypertension
por: Stene Hurtsén, Anna, et al.
Publicado: (2020) -
Role of Exogenous Nitric Oxide Donor in Treatment of Decompensated Hemorrhagic Shock in Normotensive and Hypertensive Rats
por: Khazaei, Majid, et al.
Publicado: (2012)